Severe ObesityBEHOMENCT07782281
Early Discharge With Hospital-at-Home After Bariatric Surgery and Economic Evaluation.
An observational study of Severe Obesity and Morbid Obesity Requiring Bariatric Surgery, run by Corporacion Parc Tauli at 1 site in Spain.
Trial summary
Bariatric surgery is the most effective treatment for severe obesity and its associated diseases. Advances in surgical techniques, enhanced recovery protocols, and multimodal perioperative care have made earlier hospital discharge possible while maintaining patient safety. Read more about this study
- Who is it for?
- Ages 18 to 65 years
- Conditions the study is for
- Severe Obesity, Morbid Obesity Requiring Bariatric Surgery
- How many people
- 300 participants
- Where
- 1 siteSpain
- Study dates
- 15 Feb 2025to Jan 2028
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 65 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: The study population consists of adult patients with severe obesity undergoing elective bariatric surgery at Hospital Universitari Parc Taulí. The study includes two consecutive cohorts: patients treated before implementation of the early discharge pathway with conventional postoperative hospitalization, and patients treated after implementation of the early discharge pathway with Hospital-at-Home care as part of routine clinical practice.
Who may be able to join
- Age 18 years or older.
- Patients undergoing elective bariatric surgery.
- Bariatric surgery performed during the predefined study periods for either cohort.
- Availability of sufficient clinical and economic data for study analysis.
Who cannot join
- Emergency surgery.
- Intraoperative complications requiring postoperative management outside the standard care pathway.
- Unplanned admission to an intensive care unit.
- Incomplete clinical or economic data preventing study analysis.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Spain1 site, 1 recruiting
- Recruiting
Hospital Universitari Parc Taulí
Sabadell, Barcelona, 08758
Noelia Pérez Romero, MD, PhD, +34 696848757, 35667npr@gmail.com
About this study
Official title: Economic Evaluation of an Early Discharge Pathway With Hospital-at-Home After Bariatric Surgery in Patients Undergoing Bariatric Surgery: A Comparative Observational Cohort Study
Bariatric surgery is the most effective treatment for severe obesity and its associated diseases. Advances in surgical techniques, enhanced recovery protocols, and multimodal perioperative care have made earlier hospital discharge possible while maintaining patient safety.
This observational cohort study aims to evaluate the economic impact of an early discharge pathway consisting of 24 hours of hospital stay followed by Hospital-at-Home care, compared with the conventional 48-hour hospital stay after bariatric surgery.
The study will compare healthcare costs, resource utilization, clinical safety, organizational efficiency, applicability of the early discharge pathway, and patient satisfaction between both postoperative care models under routine clinical practice.
Read the detailed description
The implementation of Enhanced Recovery After Surgery (ERAS) protocols, minimally invasive surgical techniques, and optimized multimodal perioperative management has significantly improved postoperative recovery after bariatric surgery, allowing earlier hospital discharge without compromising patient safety.
At Hospital Universitari Parc Taulí, an early discharge pathway combining 24 hours of postoperative hospital stay with structured Hospital-at-Home (HaH) care during the second postoperative day was implemented as part of routine clinical practice in February 2025. This model was developed to optimize healthcare resource utilization while maintaining the same overall duration of postoperative medical supervision as the conventional pathway.
This study is an ambispective comparative observational cohort study designed to evaluate the economic impact of this postoperative care pathway under real-world clinical conditions. Patients managed with the conventional 48-hour hospital stay before implementation of the protocol will be compared with patients managed using the early discharge plus Hospital-at-Home pathway after implementation.
The study will evaluate direct healthcare costs, healthcare resource utilization, clinical safety, organizational efficiency, applicability of the early discharge pathway, and patient satisfaction. The results are expected to provide evidence regarding the economic and organizational impact of Hospital-at-Home as an alternative postoperative care model following bariatric surgery within a public healthcare system.
- Keywords
- bariatric surgery, early discharge, hospiral-at-home, enhanced recovery after surgery, ERAS, healthcare costs, health resource utilization, economic evaluation, postoperative care, severe obesity
- Medical subject headings
- Obesity, Morbid
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| Conventional Hospital Stay | Patients who underwent elective bariatric surgery before implementation of the early discharge pathway and received conventional postoperative care with approximately 48 hours of inpatient hospital stay. | |
| Early Discharge With Hospital-at-Home | Patients who underwent elective bariatric surgery after implementation of the early discharge pathway and received 24 hours of inpatient hospital stay followed by structured Hospital-at-Home care during the second postoperative day. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Mean Direct Healthcare Cost per Patient
Mean direct healthcare cost per patient, including hospital stay, Hospital-at-Home care, emergency department visits, hospital readmissions, and additional healthcare resources used during the postoperative follow-up period.
Measured: Within 90 days after bariatric surgery
Secondary outcomes (8)
Length of Hospital Stay
Length of conventional inpatient hospital stay following bariatric surgery, measured in days.
Measured: From surgery until hospital discharge (approximately 24-48 hours).
Hospital-at-Home Utilization
Utilization of the Hospital-at-Home program, assessed by the number of home care days and home visits provided after hospital discharge.
Measured: During the Hospital-at-Home follow-up period (postoperative day 2).
Emergency Department Visits
Number of postoperative emergency department visits occurring during the follow-up period, regardless of the reason for consultation.
Measured: Within 90 days after bariatric surgery.
Hospital Readmissions
Number of hospital readmissions occurring during the postoperative follow-up period.
Measured: Within 90 days after bariatric surgery.
Postoperative Complications
Incidence and severity of postoperative complications, including complications classified according to the Clavien-Dindo classification, reinterventions, and postoperative mortality.
Measured: Within 90 days after bariatric surgery.
Hospital Bed-Days Saved
Number of conventional hospital bed-days saved by implementing the early discharge pathway with Hospital-at-Home compared with the conventional postoperative care pathway.
Measured: Perioperative (from surgery until hospital discharge, up to 48 hours)
Applicability of the Early Discharge Pathway
Proportion of patients eligible for and successfully managed with the early discharge pathway including Hospital-at-Home care, as well as the reasons for non-inclusion when applicable.
Measured: Perioperative (from surgery until discharge allocation, up to 48 hours)
Patient Satisfaction
Patient satisfaction assessed using a structured questionnaire evaluating the information received, hospital stay, Hospital-at-Home care, anxiety related to home recovery, overall satisfaction, willingness to repeat the care pathway, and willingness to recommend it to other patients.
Measured: At completion of postoperative follow-up (within 90 days after bariatric surgery).
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted24 Aug 2026
- Study start15 Feb 2025
- Primary completionJan 2028 (estimated)
- Study completionJan 2028 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Severe ObesityStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Other
- Enrolment
- 300 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Corporacion Parc Tauli
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Noelia Pérez Romero, Corporacion Parc Tauli
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07782281
- Sponsor's protocol ID
- PT-BEHOME-2026
- Other IDs
- CEIm 2026.176-50
- Acronym
- BEHOME
- Status last verified
- Aug 2026
- First submitted
- 19 Aug 2026
- Last updated
- 24 Aug 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: Individual participant data will not be shared because the study involves pseudonymized clinical and economic data collected as part of routine clinical practice, and participant consent does not include data sharing with external researchers.
Study at a glance
From the registry record, last updated by the sponsor on 24 Aug 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Economic Evaluation of an Early Discharge Pathway With Hospital-at-Home After Bariatric Surgery in Patients Undergoing Bariatric Surgery: A Comparative Observational Cohort Study
- ClinicalTrials.gov ID
- NCT07782281
- Acronym / sponsor ID
- BEHOME / PT-BEHOME-2026
- Keywords
- bariatric surgery, early discharge, hospiral-at-home, enhanced recovery after surgery, ERAS, healthcare costs, health resource utilization, economic evaluation
- Study type
- Observational
- Recruitment status
- Recruiting
- Enrolment
- 300 participants (estimated)
- Lead sponsor
- Corporacion Parc TauliUniversity, hospital or other
- Study start
- 15 Feb 2025 (actual)
- Primary completion
- Jan 2028 (estimated)
- Study completion
- Jan 2028 (estimated)
- First posted
- 24 Aug 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Bariatric surgery is the most effective treatment for severe obesity and its associated diseases. Advances in surgical techniques, enhanced recovery protocols, and multimodal perioperative care have made earlier hospital discharge possible while maintaining patient safety.
This observational cohort study aims to evaluate the economic impact of an early discharge pathway consisting of 24 hours of hospital stay followed by Hospital-at-Home care, compared with the conventional 48-hour hospital stay after bariatric surgery.
The study will compare healthcare costs, resource utilization, clinical safety, organizational efficiency, applicability of the early discharge pathway, and patient satisfaction between both postoperative care models under routine clinical practice.
Detailed description
The implementation of Enhanced Recovery After Surgery (ERAS) protocols, minimally invasive surgical techniques, and optimized multimodal perioperative management has significantly improved postoperative recovery after bariatric surgery, allowing earlier hospital discharge without compromising patient safety.
At Hospital Universitari Parc Taulí, an early discharge pathway combining 24 hours of postoperative hospital stay with structured Hospital-at-Home (HaH) care during the second postoperative day was implemented as part of routine clinical practice in February 2025. This model was developed to optimize healthcare resource utilization while maintaining the same overall duration of postoperative medical supervision as the conventional pathway.
This study is an ambispective comparative observational cohort study designed to evaluate the economic impact of this postoperative care pathway under real-world clinical conditions. Patients managed with the conventional 48-hour hospital stay before implementation of the protocol will be compared with patients managed using the early discharge plus Hospital-at-Home pathway after implementation.
The study will evaluate direct healthcare costs, healthcare resource utilization, clinical safety, organizational efficiency, applicability of the early discharge pathway, and patient satisfaction. The results are expected to provide evidence regarding the economic and organizational impact of Hospital-at-Home as an alternative postoperative care model following bariatric surgery within a public healthcare system.
Study design
- Observational model
- Cohort
- Time perspective
- Other
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Conventional Hospital Stay | – | –Patients who underwent elective bariatric surgery before implementation of the early discharge pathway and received conventional postoperative care with approximately 48 hours of inpatient hospital stay. |
| Early Discharge With Hospital-at-Home | – | –Patients who underwent elective bariatric surgery after implementation of the early discharge pathway and received 24 hours of inpatient hospital stay followed by structured Hospital-at-Home care during the second postoperative day. |
Who may qualify
- Ages
- 18 to 65 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- The study population consists of adult patients with severe obesity undergoing elective bariatric surgery at Hospital Universitari Parc Taulí. The study includes two consecutive cohorts: patients treated before implementation of the early discharge pathway with conventional postoperative hospitalization, and patients treated after implementation of the early discharge pathway with Hospital-at-Home care as part of routine clinical practice.
Key inclusion criteria (4 listed)
- Age 18 years or older.
- Patients undergoing elective bariatric surgery.
- Bariatric surgery performed during the predefined study periods for either cohort.
- Availability of sufficient clinical and economic data for study analysis.
Key exclusion criteria (4 listed)
- Emergency surgery.
- Intraoperative complications requiring postoperative management outside the standard care pathway.
- Unplanned admission to an intensive care unit.
- Incomplete clinical or economic data preventing study analysis.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Mean Direct Healthcare Cost per Patient
Time frame: Within 90 days after bariatric surgery
Mean direct healthcare cost per patient, including hospital stay, Hospital-at-Home care, emergency department visits, hospital readmissions, and additional healthcare resources used during the postoperative follow-up period.
8 secondary outcomes
Length of Hospital Stay
Time frame: From surgery until hospital discharge (approximately 24-48 hours).
Hospital-at-Home Utilization
Time frame: During the Hospital-at-Home follow-up period (postoperative day 2).
Emergency Department Visits
Time frame: Within 90 days after bariatric surgery.
Hospital Readmissions
Time frame: Within 90 days after bariatric surgery.
Postoperative Complications
Time frame: Within 90 days after bariatric surgery.
Hospital Bed-Days Saved
Time frame: Perioperative (from surgery until hospital discharge, up to 48 hours)
Applicability of the Early Discharge Pathway
Time frame: Perioperative (from surgery until discharge allocation, up to 48 hours)
Patient Satisfaction
Time frame: At completion of postoperative follow-up (within 90 days after bariatric surgery).
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 24 Aug 2026.
- Individual participant dataSharing planned: No. Individual participant data will not be shared because the study involves pseudonymized clinical and economic data collected as part of routine clinical practice, and participant consent does not include data sharing with external researchers.
Related trials for Severe Obesity
Not yet recruitingObservational study
Pilot Study on the Effectiveness and Safety of OPTILENE® SILVER MESH ELASTIC in Prevention of Surgical Site Infection (SSI) and Incisional Hernia (IH)
Abdominal Aortic Aneurysm, Morbid Obesity
Not yet recruitingObservational study
Evaluating Metabolic Health in Individuals With Extreme Obesity
BMI>40
RecruitingPhase 3
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
Crohn's Disease, Obesity or Overweight
RecruitingPhase 3
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
Ulcerative Colitis, Obesity or Overweight
Active, not recruitingPhase 3
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Study to Evaluate the Efficacy and Safety of HRS9531 Injection in Subjects With Obstructive Sleep Apnea (OSA) and Obesity Who Are on Positive Airway Pressure Ventilation (PAP) Therapy
Subjects With Moderate-to-severe OSA and Obesity Who Are on PAP Therapy
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Severe Obesity and Morbid Obesity Requiring Bariatric Surgery, run by Corporacion Parc Tauli at 1 site in Spain.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 24 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Noelia Pérez Romero, MD, PhD (696848757, 35667npr@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Mean Direct Healthcare Cost per Patient (time frame: Within 90 days after bariatric surgery). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Aug 2026.